Legacy Cancer Institute uterine cancer patient survival rates

See these numbers in graph form here. 

The tables below show Legacy Cancer Institute patient survival rates as compared to 1,409 American College of Surgeons Commission on Cancer-accredited cancer programs. Data is from patients diagnosed between 2003 and 2005, the most recent available. 

Overall survival rates

   Less than 1 year  1 year 2 years  3 years   4 years  5 years
 National average  100%  92.6%  87.0%  83.0%  79.7%  79.9%
 Legacy Cancer Institute  100%  96.5%  92.2%  86.5%  84.5%  82.6%
                           

Survival rates: Patients with Stage I uterine cancer

   5 years  4 years  3 years  2 years  1 year  Less than 1 year
 National average  87.7%  90.2%  92.5%  95.0%  97.6%  51.9%
 Legacy Cancer Institute  88.2%  88.2%  90.2%  95.2%  96.2%  73.4%

Survival rates: Patients with Stage III uterine cancer

   Less than 1 year 1 year  2 years  3 years  4 years  5 years 
National average   100.0% 85.6%  71.7%  62.3%  56.3%  51.9% 
Legacy Cancer Institute   100.0% 100.0%  90.1%  83.4%  80.1%  73.4% 

During this time period, Legacy did not have enough patients with Stage II or IV cancer to show meaningful survival data for these stages.